Journal article
Frequency and prognostic impact of acute kidney injury in patients with acute pulmonary embolism. Data from the RIETE registry.
- Murgier M Medical-Surgical Intensive Care Unit, Hôpital-Nord Saint-Etienne University Hospital, Avenue Albert Raimond, Saint-Priest-en-Jarez, 42270 Saint-Etienne, France. Electronic address: martin.murgier@chu-st-etienne.fr.
- Bertoletti L Department of Vascular and Therapeutic Medicine, Saint-Etienne University Hospital, Avenue Albert Raimond, Saint-Priest-en-Jarez, France; INSERM CIC1408 and UMR 1059, Saint-Etienne, France; INNOVTE, St-Etienne, France.
- Darmon M Medical-Surgical Intensive Care Unit, Hôpital-Nord Saint-Etienne University Hospital, Avenue Albert Raimond, Saint-Priest-en-Jarez, 42270 Saint-Etienne, France.
- Zeni F Medical-Surgical Intensive Care Unit, Hôpital-Nord Saint-Etienne University Hospital, Avenue Albert Raimond, Saint-Priest-en-Jarez, 42270 Saint-Etienne, France.
- Valle R Department of Internal Medicine, Hospital Sierrallana, Santander, Spain.
- Del Toro J Department of Internal Medicine, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
- Llamas P Department of Haematology, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain.
- Mazzolai L Division of Angiology, Department of Heart and Vessel, Centre Hospitalier Universitaire Vaudois (CHUV), University of Lausanne, Lausanne, Switzerland.
- Villalobos A Department of Internal Medicine, Hospital Regional Universitario de Málaga, Málaga, Spain.
- Monreal M Department of Internal Medicine, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain.
- 2019-06-01
Published in:
- International journal of cardiology. - 2019
Acute kidney injury
Biomarkers
Bleeding
Mortality
Pulmonary embolism
Risk
Acute Kidney Injury
Aged
Aged, 80 and over
Female
Humans
Internationality
Male
Middle Aged
Mortality
Multivariate Analysis
Prognosis
Prospective Studies
Pulmonary Embolism
Registries
English
RATIONALE
Acute kidney injury (AKI) is associated with a poor outcome. Although pulmonary embolism (PE) may promote AKI through renal congestion and/or hemodynamic instability, its frequency and influence on outcome in patients with acute PE have been poorly studied.
METHODS
The frequency of AKI (defined according to the "Kidney Disease: Improving Global Outcomes" definition) at baseline and its influence on the 30-day mortality was evaluated in patients with acute PE from the RIETE (Registro Informatizado Enfermedad TromboEmbolica) registry. We used multivariate analysis to assess whether the presence of AKI influenced the risk for 30-day death.
RESULTS
The study included 21,131 patients, of whom 6222 (29.5%) had AKI at baseline: 4385 patients (21%) in stage 1, 1385 (6.5%) in stage 2 and 452 (2%) in stage 3. The proportion of patients with high-risk PE in those with no AKI, AKI stage 1, AKI stage 2 or AKI stage 3 was: 2.8%, 5.3%, 8.8% and 12%, respectively (p < 0.001). After 30 days, 1236 patients (5.9%) died. Overall mortality was 4% in patients with no AKI, 8.4% in AKI stage 1, 14% in AKI stage 2 and 17% in AKI stage 3 (all p < 0.001). AKI was independently associated with an increased risk of all-cause death at 30 days (odds ratio = 1.25; 95%CI: 1.02-1.54).
CONCLUSIONS
One in every 3-4 patients with acute PE had AKI at baseline. The presence of AKI independently predicted 30-day mortality. This study suggests that AKI may deserve to be evaluated as a prognostic factor in patients with acute PE.
Acute kidney injury (AKI) is associated with a poor outcome. Although pulmonary embolism (PE) may promote AKI through renal congestion and/or hemodynamic instability, its frequency and influence on outcome in patients with acute PE have been poorly studied.
METHODS
The frequency of AKI (defined according to the "Kidney Disease: Improving Global Outcomes" definition) at baseline and its influence on the 30-day mortality was evaluated in patients with acute PE from the RIETE (Registro Informatizado Enfermedad TromboEmbolica) registry. We used multivariate analysis to assess whether the presence of AKI influenced the risk for 30-day death.
RESULTS
The study included 21,131 patients, of whom 6222 (29.5%) had AKI at baseline: 4385 patients (21%) in stage 1, 1385 (6.5%) in stage 2 and 452 (2%) in stage 3. The proportion of patients with high-risk PE in those with no AKI, AKI stage 1, AKI stage 2 or AKI stage 3 was: 2.8%, 5.3%, 8.8% and 12%, respectively (p < 0.001). After 30 days, 1236 patients (5.9%) died. Overall mortality was 4% in patients with no AKI, 8.4% in AKI stage 1, 14% in AKI stage 2 and 17% in AKI stage 3 (all p < 0.001). AKI was independently associated with an increased risk of all-cause death at 30 days (odds ratio = 1.25; 95%CI: 1.02-1.54).
CONCLUSIONS
One in every 3-4 patients with acute PE had AKI at baseline. The presence of AKI independently predicted 30-day mortality. This study suggests that AKI may deserve to be evaluated as a prognostic factor in patients with acute PE.
- Language
-
- English
- Open access status
- closed
- Identifiers
-
- DOI 10.1016/j.ijcard.2019.04.083
- PMID 31147192
- Persistent URL
- https://sonar.ch/global/documents/186237
Export to…
Statistics
Document views: 78
File downloads: